Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours M Danta, D Brown, S Bhagani, OG Pybus, CA Sabin, M Nelson, M Fisher, ... Aids 21 (8), 983-991, 2007 | 582 | 2007 |
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression R Waziry, B Hajarizadeh, J Grebely, J Amin, M Law, M Danta, J George, ... Journal of hepatology 67 (6), 1204-1212, 2017 | 539 | 2017 |
Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men T van de Laar, O Pybus, S Bruisten, D Brown, M Nelson, S Bhagani, ... Gastroenterology 136 (5), 1609-1617, 2009 | 430 | 2009 |
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials SA Harrison, VWS Wong, T Okanoue, N Bzowej, R Vuppalanchi, ... Journal of hepatology 73 (1), 26-39, 2020 | 388 | 2020 |
Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection TJ Van De Laar, GV Matthews, M Prins, M Danta Aids 24 (12), 1799-1812, 2010 | 365 | 2010 |
Sexually transmitted hepatitis C infection: the new epidemic in MSM? D Bradshaw, G Matthews, M Danta Current opinion in infectious diseases 26 (1), 66-72, 2013 | 188 | 2013 |
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label … S Qin, M Chen, AL Cheng, AO Kaseb, M Kudo, HC Lee, AC Yopp, J Zhou, ... The Lancet 402 (10415), 1835-1847, 2023 | 169 | 2023 |
Impact of HIV on host-virus interactions during early hepatitis C virus infection M Danta, N Semmo, P Fabris, D Brown, OG Pybus, CA Sabin, S Bhagani, ... The Journal of infectious diseases 197 (11), 1558-1566, 2008 | 165 | 2008 |
Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conference European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus ... Aids 25 (4), 399-409, 2011 | 128 | 2011 |
The role of diet in the pathogenesis and management of inflammatory bowel disease: a review G Wark, D Samocha-Bonet, S Ghaly, M Danta Nutrients 13 (1), 135, 2020 | 112 | 2020 |
Transmission of HCV in HIV-positive populations M Danta, AJ Rodger Current opinion in HIV and AIDS 6 (6), 451-458, 2011 | 87 | 2011 |
HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A Meta‐Analysis I Lockart, MGH Yeo, B Hajarizadeh, GJ Dore, M Danta, K Abe, F Carrat, ... Hepatology 76 (1), 139-154, 2022 | 74 | 2022 |
Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer? DA Brown, KW Hance, CJ Rogers, LB Sansbury, PS Albert, G Murphy, ... Cancer epidemiology, biomarkers & prevention 21 (2), 337-346, 2012 | 72 | 2012 |
10th conference on retroviruses and opportunistic infections A Carr, M DYBUL, HM ROSS, C HICKS, G MOYLE, M YOULE Conf Retrovir Opportunistic Infect, Citeseer, 13, 2006 | 66 | 2006 |
Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C J Nattermann, M Vogel, HD Nischalke, M Danta, S Mauss, HJ Stellbrink, ... Journal of Infectious Diseases 203 (5), 595-601, 2011 | 63 | 2011 |
Effect of the interleukin‐6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients J Nattermann, M Vogel, T Berg, M Danta, B Axel, C Mayr, R Bruno, ... Hepatology 46 (4), 1016-1025, 2007 | 63 | 2007 |
Acute HCV in HIV-positive individuals-a review M Danta, GM Dusheiko Current pharmaceutical design 14 (17), 1690-1697, 2008 | 62 | 2008 |
Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM I Lockart, GV Matthews, M Danta Current opinion in infectious diseases 32 (1), 31-37, 2019 | 53 | 2019 |
A comparison of seminal hepatitis C virus (HCV) RNA levels during recent and chronic HCV infection in HIV-infected and HIV-uninfected individuals D Bradshaw, F Lamoury, B Catlett, TL Applegate, J Mcallister, GJ Dore, ... The Journal of infectious diseases 211 (5), 736-743, 2015 | 49 | 2015 |
Systematic review with meta‐analysis: The effects of non‐steroidal anti‐inflammatory drugs and anti‐platelet therapy on the incidence and recurrence of hepatocellular carcinoma RZH Tan, I Lockart, C Abdel Shaheed, M Danta Alimentary pharmacology & therapeutics 54 (4), 356-367, 2021 | 44 | 2021 |